Aerie bags an early OK for its self-described blockbuster glaucoma drug Rhopressa, recruiting 100 reps
The FDA has approved Aerie’s $AERI glaucoma drug Rhopressa, hitting the green light a full two months ahead of the PDUFA date.
This wasn …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
